Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 114201-114250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT02456090
PaTH Clinical Data Research Network (CDRN) Study of Healthy Lifestyles and Health Care
N/AActive, not recruiting
1,500 participants
Started: May 31, 2015 · Completed: Jul 31, 2030
1 condition5 sponsors5 locations
NCT03214263
Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases
N/ARecruiting
20,000 participants
Started: May 31, 2015 · Completed: Dec 31, 2024
5 conditions13 sponsors11 locations
NCT02413970
Inspire® Post-Approval Study / Protocol Number 2014-001
NAActive, not recruiting
127 participants
Started: May 31, 2015 · Completed: Jun 30, 2025
1 condition1 sponsor14 locations
NCT02368041
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
N/ARecruiting
130 participants
Started: May 31, 2015 · Completed: May 10, 2026
1 condition1 sponsor1 location
NCT05753124
Effect of Obesity, Diabetes and Bariatric Surgery on Pregnancy Outcomes
N/ARecruiting
700 participants
Started: May 31, 2015 · Completed: Oct 31, 2027
5 conditions1 sponsor1 location
NCT02793999
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
N/ARecruiting
125 participants
Started: May 31, 2015 · Completed: May 31, 2027
2 conditions4 sponsors3 locations
NCT02508454
The Miami Heart Study at Baptist Health South Florida
N/AActive, not recruiting
4,000 participants
Started: May 31, 2015 · Completed: Sep 30, 2028
1 condition3 sponsors1 location
NCT02461446
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
N/ARecruiting
170 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
5 conditions6 sponsors5 locations
NCT06239142
Understanding Mental Fatigue After Subarachnoid Hemorrhage
N/AActive, not recruiting
64 participants
Started: May 31, 2015 · Completed: Jun 30, 2024
2 conditions1 sponsor0 locations
NCT02252380
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
NAActive, not recruiting
10 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
9 conditions1 sponsor2 locations
NCT02512250
Swiss Hemophilia Registry
N/ARecruiting
900 participants
Started: May 31, 2015 · Completed: Dec 31, 2025
1 condition1 sponsor19 locations
NCT02450708
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
NAActive, not recruiting
511 participants
Started: May 31, 2015 · Completed: May 31, 2026
1 condition9 sponsors10 locations
NCT02413736
Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST
PHASE3Active, not recruiting
255 participants
Started: May 31, 2015 · Completed: Jun 30, 2033
1 condition2 sponsors1 location
NCT02647177
A Prospective Study To Identify Predictive Biological Markers In Blood And Cyst Fluid Aspirates From Patients With Pancreatic Cyst Lesions
N/ARecruiting
1,000 participants
Started: May 31, 2015 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT02415413
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
PHASE2Active, not recruiting
90 participants
Started: May 31, 2015 · Completed: Jun 30, 2027
1 condition3 sponsors16 locations
NCT02455505
Identifying Family Members in Need of Support While Caregiving and After Loss
N/AActive, not recruiting
52 participants
Started: May 31, 2015 · Completed: May 31, 2027
1 condition4 sponsors2 locations
NCT02505464
Pregnancies Complicated by Fetal Anomalies
N/ARecruiting
500 participants
Started: May 31, 2015 · Completed: Apr 30, 2028
2 conditions2 sponsors5 locations
NCT02425904
Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders
PHASE2Active, not recruiting
25 participants
Started: May 31, 2015 · Completed: Jan 31, 2026
1 condition5 sponsors15 locations
NCT02422641
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
PHASE2Recruiting
16 participants
Started: May 31, 2015 · Completed: Jan 31, 2027
2 conditions2 sponsors3 locations
NCT02437526
Analytic Treatment Interruption (ATI) to Assess HIV Cure
NAEnrolling by invitation
10 participants
Started: May 31, 2015 · Completed: May 31, 2035
1 condition1 sponsor1 location
NCT02283281
Anesthetic Premedication With a Cannabis Extract (Cannapremed)
PHASE2/PHASE3Recruiting
200 participants
Started: May 31, 2015 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location
NCT02674217
Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells
NAEnrolling by invitation
1,000 participants
Started: May 31, 2015 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT02506361
Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer
N/ARecruiting
800 participants
Started: May 31, 2015 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT02445885
Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
NARecruiting
150 participants
Started: May 31, 2015 · Completed: Mar 1, 2039
2 conditions1 sponsor1 location
NCT04484064
Optimization of the Targeted Anticancer Therapies
NARecruiting
500 participants
Started: May 31, 2015 · Completed: Dec 31, 2030
1 condition3 sponsors1 location
NCT02454543
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases
NAActive, not recruiting
452 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT02447874
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
PHASE1/PHASE2Recruiting
21 participants
Started: May 31, 2015 · Completed: Jul 31, 2026
1 condition3 sponsors2 locations
NCT01704586
I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer
NARecruiting
340 participants
Started: May 31, 2015 · Completed: Nov 30, 2025
1 condition2 sponsors2 locations
NCT02347722
Biomarkers to Classify Heart Failure
N/AActive, not recruiting
511 participants
Started: May 31, 2015 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT02394834
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
N/AActive, not recruiting
757 participants
Started: May 29, 2015 · Completed: Mar 31, 2026
1 condition1 sponsor151 locations
NCT02311933
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
PHASE2Active, not recruiting
81 participants
Started: May 28, 2015 · Completed: Feb 4, 2026
6 conditions1 sponsor563 locations
NCT02393625
Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer
PHASE1Active, not recruiting
57 participants
Started: May 27, 2015 · Completed: Apr 9, 2026
1 condition1 sponsor12 locations
NCT02400190
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NAActive, not recruiting
202 participants
Started: May 27, 2015 · Completed: May 31, 2026
1 condition12 sponsors13 locations
NCT05908123
Exploring the Nature, Assessment and Treatment of Stuttering
NARecruiting
3,000 participants
Started: May 22, 2015 · Completed: May 22, 2035
4 conditions1 sponsor1 location
NCT02474160
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
N/ARecruiting
5,000 participants
Started: May 19, 2015 · Completed: May 4, 2026
4 conditions2 sponsors140 locations
NCT02257528
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
PHASE2Active, not recruiting
26 participants
Started: May 18, 2015 · Completed: Mar 17, 2026
6 conditions2 sponsors333 locations
NCT02208362
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PHASE1Active, not recruiting
65 participants
Started: May 18, 2015 · Completed: Jun 8, 2026
8 conditions3 sponsors1 location
NCT03209791
Ethanol Induces Skeletal Muscle Autophagy
N/ARecruiting
40 participants
Started: May 18, 2015 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04565366
Transforming Research and Clinical Knowledge in Spinal Cord Injury
N/AEnrolling by invitation
726 participants
Started: May 14, 2015 · Completed: Dec 1, 2028
1 condition4 sponsors5 locations
NCT02314169
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
PHASE2Active, not recruiting
37 participants
Started: May 13, 2015 · Completed: Mar 21, 2026
3 conditions1 sponsor56 locations
NCT02383342
Pain Predict Genetics
N/ARecruiting
10,000 participants
Started: May 12, 2015 · Completed: Mar 31, 2029
2 conditions1 sponsor1 location
NCT02652078
Shockwave Therapy in Lower Limb Intermittent Calf Claudication
NAActive, not recruiting
138 participants
Started: May 11, 2015 · Completed: Feb 1, 2030
1 condition2 sponsors1 location
NCT02390518
Stereotactic Radiosurgery Dose Escalation for Brain Metastases
PHASE1Recruiting
50 participants
Started: May 7, 2015 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT02438722
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
PHASE2/PHASE3Active, not recruiting
174 participants
Started: May 7, 2015 · Completed: Nov 15, 2025
2 conditions2 sponsors638 locations
NCT04254731
Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals
PHASE4Active, not recruiting
10 participants
Started: May 7, 2015 · Completed: Jul 30, 2024
3 conditions1 sponsor3 locations
NCT02411448
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
PHASE3Active, not recruiting
545 participants
Started: May 6, 2015 · Completed: Dec 31, 2025
1 condition1 sponsor106 locations
NCT05780502
Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders
N/ARecruiting
370 participants
Started: May 6, 2015 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT02438904
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
NARecruiting
200 participants
Started: May 6, 2015 · Completed: May 1, 2027
1 condition1 sponsor1 location
NCT02449421
Sustaining and Improving Clinicians' Use of Evidence-Based Psychotherapy (EBP) for PTSD
NAActive, not recruiting
90 participants
Started: May 6, 2015 · Completed: Jun 30, 2024
1 condition6 sponsors3 locations
NCT02435810
Inflammatory and Infectious Diseases of the Nervous System
N/ARecruiting
1,000 participants
Started: May 6, 2015 · Completed: Nov 29, 2025
1 condition1 sponsor1 location